These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 5821999)

  • 21. [Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases].
    Osugi S
    Jpn Circ J; 1971 Feb; 35(2):268-80. PubMed ID: 5109720
    [No Abstract]   [Full Text] [Related]  

  • 22. [Coronary drugs].
    de Lostalot J; Quilichini R
    Bord Med; 1972 Feb; 5(4):343-54. PubMed ID: 4402981
    [No Abstract]   [Full Text] [Related]  

  • 23. [Electromechanical uncoupling on the uterine muscle by "musculotropic" relaxants].
    Grün G; Fleckenstein A; Tritthart H
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):239-40. PubMed ID: 4242391
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of extracellular calcium concentration on the effect of coronary dilatators (action mechanism of coronary dilatators)].
    Kosche F; Raff KW; Lochner W
    Pflugers Arch; 1972; 335(1):46-57. PubMed ID: 4627535
    [No Abstract]   [Full Text] [Related]  

  • 25. [Behavior of the microcirculation in the experimental treatment of coronary insufficiency with verapamil and the clinical use of verapamil in revascularization of the heart].
    Svecov IM; Derzavez LC; Krutik IG; Culkova IP; Dobrochotov GS
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1328+. PubMed ID: 5536557
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antagonistic influencing of circulatory reactions following angiotensin and vasopressin in the anesthetized dog].
    Becker KH; Lorenz D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):95. PubMed ID: 4306398
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of Verapamil on the metabolism of myocardium].
    Haas H; Gokel M
    Arzneimittelforschung; 1970 May; 20(5):647-55. PubMed ID: 4393245
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs and myocardial blood flow.
    Rees JR
    Proc R Soc Med; 1969 Jan; 62(1):79-84. PubMed ID: 4974072
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitative and comparative studies of pharmacological features in the coronary, femoral and renal circulations with different coronary vasodilators.
    Oguro K; Hashimoto K
    Jpn J Pharmacol; 1974 Apr; 24(2):227-33. PubMed ID: 4212295
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].
    Fleckenstein A; Tritthart H; Flackenstein B; Herbst A; Grün G
    Pflugers Arch; 1969; 307(2):R25. PubMed ID: 5814829
    [No Abstract]   [Full Text] [Related]  

  • 31. [Reversible blockade of excitation-contraction coupling in rat's uterine smooth muscle by means of organic calcium antagonists (iproveratril, D 600, prenylamine)].
    Fleckenstein A; Grün G
    Pflugers Arch; 1969; 307(2):R26. PubMed ID: 5814830
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficacy of various coronary dilators following enteral application in the anesthetized dog].
    Lorenz D; Dell HD
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):272-3. PubMed ID: 4242418
    [No Abstract]   [Full Text] [Related]  

  • 33. [Limitation of the disappearance of energy-rich phosphate compounds in the hyperactive atrial and ventricular myocardium by divalent Ca-antagonistic inhibitors of electromechanical coupling (iprovdratril, D 600, prenylamine)].
    Doring HJ; Leder O; Jaedicke W; Reindell A; Fleckenstein A
    Pflugers Arch; 1969; 312(1):R7-8. PubMed ID: 5390299
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacology and clinical effects of lidoflazine].
    Janssen PA
    Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
    [No Abstract]   [Full Text] [Related]  

  • 35. [Is adenosine the mediator for the regulation of the coronary circulation and for the effect of coronarodilators? Review].
    Meisel M; Meisel P
    Pharmazie; 1974 Sep; 29(9):361-8. PubMed ID: 4213610
    [No Abstract]   [Full Text] [Related]  

  • 36. The possible role of an adrenergic mechanism in the antianginal action of papaverine and prenylamine.
    Szekeres L; Papp JG; Fischer E
    Eur J Pharmacol; 1967 Oct; 2(1):1-8. PubMed ID: 4384753
    [No Abstract]   [Full Text] [Related]  

  • 37. [The influence of orally applied iproveratril (Verapamil) on coronayy blood flow, oxygen consumption and carbon dioxide formation in the human heart].
    Rudolph W; Kriener J; Meister W
    Arzneimittelforschung; 1971 Apr; 21(4):462-5. PubMed ID: 5108271
    [No Abstract]   [Full Text] [Related]  

  • 38. [Parallel influence of isometric tension development and O2 consumption of isolated papillary muscles under the influence of Ca ions, adrenaline, isoproteranol and organic Ca antagonists (iproveratril, D 600, prenylamine)].
    Byon KY; Fleckenstein A
    Pflugers Arch; 1969; 312(1):R8-9. PubMed ID: 5390309
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of the effect of a coronary vasodilator].
    Nakamura Y; Nagoshi H; Takei F; Takahashi M; Matsumura N
    Kokyu To Junkan; 1972 Sep; 20(9):805-9. PubMed ID: 4676839
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical trials of the effect of verapamil in subjects with angina pectoris].
    De Liperi E; Coli R; Brunori F; Singer MT
    Minerva Med; 1970 Dec; 61(97):5562-73. PubMed ID: 5494125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.